Feldman R, Rosen Z. NIH Licensing Would Benefit from Free-Market Provisions.
J Law Med Ethics 2024;
51:24-27. [PMID:
38433679 DOI:
10.1017/jme.2024.1]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/05/2024]
Abstract
Government encouragement of free markets is a highly effective means of fostering pharmaceutical innovation; the NIH, by including "free-market provisions" in its licensing agreements that discourage anti-competitive and research-impeding behavior, can do a great deal to support this goal even without legislative overhaul.
Collapse